Allergic rhinitis, unspecified
Conditions
Interventions
This clinical trial has a cross-sectional, randomized, controlled, double-blind crossover clinical trial that will evaluate children and adolescents from the outpatient clinic of the Discipline of All
Sponsors
Escola Paulista de Medicina
Escola Paulista de Medicina
Eligibility
Age
8 Years to 17 Years
Inclusion criteria
Inclusion criteria: Age between 8 and 17 years old, medical diagnosis of RA (ARIA) present in the medical record for at least 12 months; allergic sensitization by immediate reading skin test (Prick test) or specific serum IgE to at least one inhaled allergen in the last 12 months; degree of nasal obstruction with values equal to five on the day of the test on a visual analogue scale (5 to 10).
Exclusion criteria
Exclusion criteria: Severe or uncontrolled asthma; use of topical medication (nasal decongestant in the last 24 hours); topical corticosteroids within two weeks; use of oral medication: systemic corticosteroids within the last four weeks,chromones within d weeks, antihistamines within a week or immunotherapy five years before the start of the study; severe systemic disease; history or signs of upper or lower respiratory infection within the last four weeks; anatomical defects of the upper airways (nasal polyposis, adenoid hypertrophy, deviated septum, tumor mass) documented in the medical record or observed on physical examination; maxillary atresia; history of epistaxis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a mean difference in the parameters evaluated for patient improvement in the state of nasal obstruction after application of laser therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactEscola de Medicina
Universidade Federal de São Paulo
Outcome results
None listed